nodes	percent_of_prediction	percent_of_DWPC	metapath
Anileridine—Loperamide—POMC—asthma	0.0085	0.862	CrCbGaD
Anileridine—OPRM1—G alpha (i) signalling events—BDKRB2—asthma	0.0026	0.00263	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—asthma	0.00259	0.00261	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPY—asthma	0.00252	0.00255	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—ADCY2—asthma	0.00252	0.00254	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CYSLTR1—asthma	0.0025	0.00253	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—asthma	0.00243	0.00246	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—C5AR1—asthma	0.00242	0.00244	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—UTS2—asthma	0.00242	0.00244	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL11—asthma	0.00242	0.00244	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—BDKRB2—asthma	0.00241	0.00244	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—CD4—asthma	0.00241	0.00244	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—KNG1—asthma	0.00237	0.00239	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—EDN1—asthma	0.00236	0.00239	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCL5—asthma	0.00235	0.00237	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRB—asthma	0.00233	0.00235	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCR4—asthma	0.00232	0.00234	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—asthma	0.00231	0.00233	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—asthma	0.00231	0.00233	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CXCL10—asthma	0.0023	0.00232	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—C3AR1—asthma	0.00228	0.0023	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—asthma	0.00226	0.00228	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL1B—asthma	0.00223	0.00225	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CYSLTR2—asthma	0.00219	0.00222	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—asthma	0.00218	0.0022	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—C5—asthma	0.00215	0.00218	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—TACR1—asthma	0.00215	0.00218	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PTGDR—asthma	0.00212	0.00214	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—LTB4R—asthma	0.00212	0.00214	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCR5—asthma	0.00211	0.00213	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—asthma	0.00207	0.00209	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—C3AR1—asthma	0.00207	0.00209	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—asthma	0.00207	0.00209	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—C3—asthma	0.00207	0.00209	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CYSLTR2—asthma	0.00199	0.00201	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CCL5—asthma	0.00198	0.002	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCR3—asthma	0.00197	0.00199	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—LTB4R—asthma	0.00192	0.00194	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PTGDR—asthma	0.00192	0.00194	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL22—asthma	0.00192	0.00194	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—NPY—asthma	0.00192	0.00194	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—asthma	0.00188	0.0019	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—asthma	0.00187	0.00189	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—AGTR2—asthma	0.00185	0.00187	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—asthma	0.00183	0.00185	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—HRH4—asthma	0.0018	0.00182	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PMCH—asthma	0.0018	0.00182	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPSR1—asthma	0.0018	0.00182	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PTGDR2—asthma	0.0018	0.00182	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CCR5—asthma	0.00178	0.0018	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	0.00177	0.00179	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—EDNRB—asthma	0.00177	0.00179	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CSF2RB—asthma	0.00176	0.00178	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—NPS—asthma	0.00176	0.00177	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—TAC1—asthma	0.00176	0.00177	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—C3—asthma	0.00174	0.00176	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—TGFB1—asthma	0.00173	0.00175	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—TACR2—asthma	0.00173	0.00174	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR8—asthma	0.00173	0.00174	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCR3—asthma	0.00172	0.00174	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—asthma	0.00165	0.00167	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—POMC—asthma	0.00165	0.00167	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PTGDR2—asthma	0.00164	0.00165	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PMCH—asthma	0.00164	0.00165	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HRH4—asthma	0.00164	0.00165	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPSR1—asthma	0.00164	0.00165	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCL2—asthma	0.00162	0.00163	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CSF2RB—asthma	0.0016	0.00162	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.00159	0.0016	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—BDKRB2—asthma	0.00157	0.00159	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.00157	0.00159	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—TACR2—asthma	0.00157	0.00158	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR8—asthma	0.00157	0.00158	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL17—asthma	0.00154	0.00155	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PDE4A—asthma	0.00151	0.00153	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—KNG1—asthma	0.00143	0.00145	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—AGTR1—asthma	0.00142	0.00144	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	0.00142	0.00143	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CYSLTR1—asthma	0.00141	0.00143	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—POMC—asthma	0.00139	0.00141	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCL10—asthma	0.00139	0.00141	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.00139	0.0014	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PDE4A—asthma	0.00137	0.00139	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—UTS2—asthma	0.00137	0.00138	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—C5AR1—asthma	0.00137	0.00138	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—VIP—asthma	0.00137	0.00138	CbGpPWpGaD
Anileridine—Pethidine—ALB—asthma	0.00136	0.138	CrCbGaD
Anileridine—OPRM1—GPCR ligand binding—ADRB2—asthma	0.00135	0.00136	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR4—asthma	0.00131	0.00132	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL6—asthma	0.0013	0.00132	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CYSLTR1—asthma	0.00128	0.0013	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CXCL8—asthma	0.00128	0.00129	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL2RB—asthma	0.00126	0.00127	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PDE4D—asthma	0.00125	0.00126	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—VIP—asthma	0.00124	0.00125	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL11—asthma	0.00124	0.00125	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—UTS2—asthma	0.00124	0.00125	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—C5AR1—asthma	0.00124	0.00125	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—C3AR1—asthma	0.00122	0.00124	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FCER2—asthma	0.00122	0.00124	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—TACR1—asthma	0.00122	0.00123	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—C5—asthma	0.00122	0.00123	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PDE4B—asthma	0.00122	0.00123	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—EDN1—asthma	0.00121	0.00122	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL5—asthma	0.0012	0.00121	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR4—asthma	0.00119	0.0012	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CYSLTR2—asthma	0.00118	0.00119	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL2RB—asthma	0.00114	0.00116	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL22—asthma	0.00114	0.00115	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTGDR—asthma	0.00114	0.00115	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LTB4R—asthma	0.00114	0.00115	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PDE4D—asthma	0.00113	0.00115	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR3—asthma	0.00111	0.00112	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	0.00111	0.00112	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—C5—asthma	0.00111	0.00112	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PDE4B—asthma	0.00111	0.00112	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—TACR1—asthma	0.00111	0.00112	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPY—asthma	0.00108	0.0011	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	0.00108	0.00109	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCR5—asthma	0.00108	0.00109	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CXCL8—asthma	0.00108	0.00109	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—C3—asthma	0.00105	0.00107	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AGTR2—asthma	0.00105	0.00106	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR3—asthma	0.00101	0.00102	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—EDNRB—asthma	0.001	0.00101	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—TAC1—asthma	0.000992	0.001	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPS—asthma	0.000992	0.001	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPY—asthma	0.000985	0.000995	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCR3—asthma	0.000973	0.000983	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTGDR2—asthma	0.000967	0.000976	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPSR1—asthma	0.000967	0.000976	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HRH4—asthma	0.000967	0.000976	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PMCH—asthma	0.000967	0.000976	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AGTR2—asthma	0.000951	0.00096	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CSF2RB—asthma	0.000946	0.000955	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TACR2—asthma	0.000927	0.000936	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR8—asthma	0.000927	0.000936	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL5—asthma	0.000923	0.000932	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—EDNRB—asthma	0.00091	0.000919	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL17—asthma	0.000909	0.000918	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—TAC1—asthma	0.000901	0.00091	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPS—asthma	0.000901	0.00091	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—BDKRB2—asthma	0.00089	0.000899	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCR3—asthma	0.000884	0.000892	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ADCY2—asthma	0.000861	0.00087	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL3—asthma	0.000858	0.000867	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	0.000857	0.000866	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—POMC—asthma	0.000844	0.000852	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL5—asthma	0.000838	0.000846	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL2—asthma	0.000825	0.000834	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDE4A—asthma	0.00081	0.000818	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KIF3A—asthma	0.00081	0.000818	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—KNG1—asthma	0.00081	0.000818	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—BDKRB2—asthma	0.000808	0.000816	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AGTR1—asthma	0.000805	0.000813	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL10—asthma	0.000787	0.000794	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ADCY2—asthma	0.000782	0.00079	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL3—asthma	0.000779	0.000787	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ADRB2—asthma	0.000764	0.000771	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CYSLTR1—asthma	0.000759	0.000766	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—KNG1—asthma	0.000735	0.000743	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL11—asthma	0.000733	0.00074	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—C5AR1—asthma	0.000733	0.00074	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—UTS2—asthma	0.000733	0.00074	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CMA1—asthma	0.000733	0.00074	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—VIP—asthma	0.000733	0.00074	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AGTR1—asthma	0.000731	0.000738	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ITPR1—asthma	0.000722	0.000729	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL10—asthma	0.000714	0.000721	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR4—asthma	0.000702	0.000709	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ADRB2—asthma	0.000693	0.0007	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STAT6—asthma	0.000689	0.000696	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—EDN1—asthma	0.000682	0.000689	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCL5—asthma	0.000677	0.000684	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL2RB—asthma	0.000676	0.000683	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDE4D—asthma	0.00067	0.000677	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CSF2—asthma	0.000667	0.000674	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ITPR1—asthma	0.000656	0.000662	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDE4B—asthma	0.000653	0.000659	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—C5—asthma	0.000653	0.000659	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TACR1—asthma	0.000653	0.000659	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCL8—asthma	0.000653	0.000659	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—EDN1—asthma	0.00062	0.000626	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL5—asthma	0.000615	0.000621	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PLA2G4A—asthma	0.000613	0.000619	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR5—asthma	0.00061	0.000616	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CSF2—asthma	0.000606	0.000612	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL2RA—asthma	0.000601	0.000607	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR3—asthma	0.000597	0.000603	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—C3—asthma	0.000596	0.000602	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPY—asthma	0.000582	0.000588	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PPP2CA—asthma	0.000564	0.00057	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AGTR2—asthma	0.000562	0.000567	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR5—asthma	0.000554	0.000559	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL2RA—asthma	0.000546	0.000551	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—C3—asthma	0.000541	0.000547	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—EDNRB—asthma	0.000538	0.000543	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPS—asthma	0.000532	0.000538	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TAC1—asthma	0.000532	0.000538	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCR3—asthma	0.000522	0.000527	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CYBA—asthma	0.000506	0.000511	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PARP1—asthma	0.000495	0.0005	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL5—asthma	0.000495	0.0005	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BDKRB2—asthma	0.000477	0.000482	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—POMC—asthma	0.000477	0.000481	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ADCY2—asthma	0.000462	0.000467	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL3—asthma	0.00046	0.000465	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KNG1—asthma	0.000434	0.000439	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—POMC—asthma	0.000433	0.000437	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AGTR1—asthma	0.000432	0.000436	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL2—asthma	0.000424	0.000428	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL6R—asthma	0.000422	0.000427	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL10—asthma	0.000422	0.000426	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—RHOA—asthma	0.00042	0.000424	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NTRK1—asthma	0.000414	0.000418	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ADRB2—asthma	0.00041	0.000414	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ITPR1—asthma	0.000387	0.000391	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—RHOA—asthma	0.000381	0.000385	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CD86—asthma	0.000369	0.000373	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL8—asthma	0.000369	0.000372	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—EDN1—asthma	0.000366	0.00037	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL5—asthma	0.000363	0.000367	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PLA2G4A—asthma	0.000362	0.000365	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CSF2—asthma	0.000358	0.000361	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL2—asthma	0.000352	0.000356	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SMAD3—asthma	0.000348	0.000352	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL8—asthma	0.000335	0.000338	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PPP2CA—asthma	0.000333	0.000337	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR5—asthma	0.000327	0.00033	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL2RA—asthma	0.000323	0.000326	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL2—asthma	0.00032	0.000323	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—C3—asthma	0.00032	0.000323	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDGFB—asthma	0.000311	0.000314	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—LEP—asthma	0.000298	0.000301	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FN1—asthma	0.000281	0.000284	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—POMC—asthma	0.000256	0.000258	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL2—asthma	0.00025	0.000253	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL6R—asthma	0.000249	0.000252	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—EGFR—asthma	0.000245	0.000247	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SERPINE1—asthma	0.000234	0.000236	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RHOA—asthma	0.000225	0.000228	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NOS3—asthma	0.000223	0.000225	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL8—asthma	0.000198	0.0002	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL2—asthma	0.000189	0.000191	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL6—asthma	0.000188	0.00019	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MMP9—asthma	0.000179	0.000181	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTEN—asthma	0.000178	0.00018	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—VEGFA—asthma	0.000161	0.000162	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STAT3—asthma	0.000159	0.000161	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TGFB1—asthma	0.000147	0.000149	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—EGFR—asthma	0.000145	0.000146	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL6—asthma	0.000111	0.000112	CbGpPWpGaD
